insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
US$118,69
arrow_downward
-0,65%(-0,78) 1D
US$118,69
0,00% (0,00)
bedtimeAfter hours
Closed: 9 ຕ.ລ., 16 ໂມງ 0 ນາທີ 04 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
US$119,81
High
US$121,19
Low
US$116,52
Mkt. cap
5,40 ຕື້
Avg. vol.
646,97 ພັນ
Volume
1,23 ລ້ານ
P/E ratio
57,89
52-wk high
US$121,19
52-wk low
US$48,17
EPS
US$2,05
Beta
0,61
Shares outstanding
45,50 ລ້ານ
No. of employees
3 ພັນ
Open
US$119,81
High
US$121,19
Low
US$116,52
Mkt. cap
5,40 ຕື້
Avg. vol.
646,97 ພັນ
Volume
1,23 ລ້ານ
P/E ratio
57,89
52-wk high
US$121,19
52-wk low
US$48,17
EPS
US$2,05
Beta
0,61
Shares outstanding
45,50 ລ້ານ
No. of employees
3 ພັນ
News stories
From web sources and news partners
Zacks
·
10 ຊົ່ວໂມງກ່ອນ
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Yahoo Finance Singapore
·
11 ຊົ່ວໂມງກ່ອນ
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Simply Wall Street
·
13 ຊົ່ວໂມງກ່ອນ
Full U.S. Rollout Could Change The Case For Haemonetics Stock
TradingView
·
23 ຊົ່ວໂມງກ່ອນ
Haemonetics Corporation Stock 12‑Month Price Target Raised to $120, Implies 18% Upside
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOChristopher Simon
Employees3,01 ພັນ
Founded1971
Headquartersບອສຕັນ, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorMedical device
Websitehaemonetics.com